Broome Oncology

Hodgkin's Lymphoma News

FDA Approves Polatuzumab Vedotin-Piiq for Diffuse Large B-Cell Lymphoma (June 25, 2019)

The FDA granted accelerated approval to polatuzumab vedotin-piiq, a CD79b-directed antibody-drug conjugate indicated in combination with bendamustine and a rituximab product for adult patients with relapsed or refractory diffuse large B-cell lymphoma... Continue Reading

FDA Approves Chemoimmunotherapy Regimen for Patients with Relapsed or Refractory Diffuse Large B-cell Lymphoma (June 11, 2019)

The U.S. Food and Drug Administration granted accelerated approval to Polivy (polatuzumab vedotin-piiq), in combination with the chemotherapy Treanda (bendamustine) and Rituxan (rituximab) product (a combination known as “BR”), to treat adult... Continue Reading

Clinical Trial Shows Best Outcomes to Date for Older Hodgkin Lymphoma Patients (September 18, 2018)

Recently published results of a phase 2 clinical trial have shown the best outcomes to date for newly diagnosed older Hodgkin lymphoma patients treated with brentuximab vedotin given before and after doxorubicin, vinblastine and dacarbazine (AVD) chemotherapy,... Continue Reading

FDA Approves Adcetris® in Combination with Chemotherapy for Previously Untreated Stage III or IV Classical Hodgkin Lymphoma (March 22, 2018)

CancerConnect News: The U.S. Food and Drug Administration (FDA) has approved Adcetris (brentuximab vedotin) in combination with chemotherapy in adult patients with previously untreated Stage III or IV classical Hodgkin lymphoma. The approval is based... Continue Reading

Addition of the Precision Cancer Medicine Adcetris Reduces the Risk of Treatment Failure in Advanced Hodgkin Lymphoma (March 1, 2018)

CancerConnect News: Patients with advanced Hodgkin lymphoma (HL) who were treated with a multi-drug regimen that included the precision cancer medicine Adcetris (brentuximab vedotin) had a 23-percent reduction in the risk of disease progression, death,... Continue Reading

Latest Hodgkin's Lymphoma News By Stage


Advanced Stage Hodgkin's Lymphoma

Sorry, there are no articles available for this cancer stage.

More Advanced Stage Hodgkin's Lymphoma

Early Stage Hodgkin's Lymphoma

Sorry, there are no articles available for this cancer stage.

More Early Stage Hodgkin's Lymphoma

Progressive Relapsed Hodgkin's Lymphoma

Sorry, there are no articles available for this cancer stage.

More Progressive Relapsed Hodgkin's Lymphoma